Back to search

Article

ClonoScreen3D: a novel three-dimensional clonogenic screening platform for identification of radiosensitizers for glioblastoma

2023-10-04

Abstract excerpt

<h4>Purpose</h4> Glioblastoma (GBM) is a lethal brain tumour. Standard of care treatment comprising surgery, radiation and chemotherapy results in median survival rates of 12-15 months. Molecular targeted agents identified using conventional two-dimensional (2D) in vitro models of GBM have failed to improve outcome in patients, rendering such models inadequate for therapeutic target identification. We developed...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
4d57e4d0-9d6e-537f-97e7-dea76e3791f9
DOI
10.1101/2023.10.04.560635
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
ClonoScreen3D: a novel three-dimensional clonogenic screening platform for identification of radiosensitizers for glioblastomaDOI 10.1101/2023.10.04.560635
Select a neighboring publication to make it the new centre.